Do patient characteristics matter when calculating sample size for eczema clinical trials?
Abstract Background The Patient‐Oriented Eczema Measure (POEM) is the core outcome instrument recommended for measuring patient‐reported atopic eczema symptoms in clinical trials. To ensure that the statistical significance of clinical trial results is meaningful, trials are often designed by specif...
Saved in:
Main Authors: | L. Howells (Author), S. Gran (Author), J. R. Chalmers (Author), B. Stuart (Author), M. Santer (Author), L. Bradshaw (Author), D. M. Gaunt (Author), M. J. Ridd (Author), L. A. A. Gerbens (Author), P. I. Spuls (Author), C. Huang (Author), N. A. Francis (Author), K. S. Thomas (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How has the COVID‐19 pandemic affected eczema self‐management and help seeking? A qualitative interview study with young people and parents/carers of children with eczema
by: M. Steele, et al.
Published: (2021) -
Adverse Events from Emollient Use in Eczema: A Restricted Review of Published Data
by: Alisha Bhanot, et al.
Published: (2019) -
Where and how have written action plans for atopic eczema/dermatitis been developed and evaluated? Systematic review
by: Charankumal Singh Thandi, et al.
Published: (2023) -
Determining the minimal important change of the recap of atopic eczema (RECAP) instrument in clinical trials
by: Arabella Baker, et al.
Published: (2024) -
Validation of the Recap of Atopic Eczema (RECAP) Measurement Instrument for Eczema Control in Adult Patients in an Asian Clinical Setting
by: Yik Weng Yew, et al.
Published: (2024)